Does Inspection of Colonic Mucosa During Insertion Improve Adenoma Detection?
INWARD
Does Careful Inspection of Colonic Mucosa During Insertion and Withdrawal During Bowel Scope Improve Rate of Adenoma Detection?
1 other identifier
interventional
490
1 country
1
Brief Summary
This is a prospective randomised controlled trial to assess an intervention of inspection during both phases of colonoscopic examination ( insertion and withdrawal) improve adenoma detection rate when compared to inspection only during withdrawal.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 27, 2017
CompletedFirst Submitted
Initial submission to the registry
August 17, 2017
CompletedFirst Posted
Study publicly available on registry
August 18, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 30, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2018
CompletedSeptember 10, 2020
September 1, 2020
1.4 years
August 17, 2017
September 9, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Adenoma detection rate
Number of participants with at least one adenoma
8 months
Secondary Outcomes (4)
Polyp detection rate
8 months
Mean number of adenoma per patient
8 months
Total procedure time
8 months
Advanced adenoma detection rate
8 months
Study Arms (2)
Inspection on withdrawal
PLACEBO COMPARATORParticipants colonic mucosa will be examined only during withdrawal phase of the examination.
Inspection on insertion and withdrawal
ACTIVE COMPARATORParticipants colonic mucosa will be examined during insertion and withdrawal phase of the examination
Interventions
Participants who are randomised to undergo the intervention will have the colonic mucosa examined during inspection and withdrawal phase of examination
Eligibility Criteria
You may qualify if:
- Participants who are referred for a bowel scope screening procedure
You may not qualify if:
- Patients lacking capacity to give informed consent
- Pregnant women
- Age less than 55 years
- Uncorrectable coagulopathy
- Patients who are not fit for flexible sigmoidoscopy
- Incomplete procedure
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
NorthWest London Hospitals - NOrthwick park hospital
Harrow, Middlesex, HA1 3UJ, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rajaratnam Rameshshanker, MBBS,MRCP
London North West Healthcare NHS Trust
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 17, 2017
First Posted
August 18, 2017
Study Start
March 27, 2017
Primary Completion
August 30, 2018
Study Completion
December 31, 2018
Last Updated
September 10, 2020
Record last verified: 2020-09
Data Sharing
- IPD Sharing
- Will not share